Cells with a CD14+/HLA-DR- phenotype are generally considered to represent monocytic MDSCs when they arise in the presence of cancer cells and have demonstrated immunosuppressive properties [10–12], though more stringent characterization as CD11b+ / CD14+ / HLA-DR- / CD15- can also be helpful [9]. This evidence concerns the gene CD14 and cancer.